News Navigation

FCB Health Network CEO and President Dana Maiman Named Med Ad News’ 2017 Industry Person of the Year

Press Release - New York, 27 April 2017

Honor Comes on Same Night as Area 23 and FCB Health Make History at Manny Awards

NEW YORK, April 27, 2017 — Interpublic Group global creative agency FCB is proud to announce that Dana Maiman, CEO and president of FCB Health, has been named “Industry Person of the Year” by Med Ad News, the pharmaceutical industry’s “publication of record” since 1982. The esteemed honor annually recognizes the very best talent in healthcare marketing – as well as the agencies, people and teams producing groundbreaking, innovative and noteworthy work in this sector – as part of its Manny Awards, and this year’s honoree was announced on Thursday, April 20, 2017, at Pier Sixty at Chelsea Piers in New York City.

“This spotlight shines across the whole host of incredible talent whom Dana leads across our family of FCB Health companies worldwide,” said FCB Worldwide CEO Carter Murray. “Her tireless efforts, dedication, passion and drive make our work for healthcare marketing clients impactful, engaging and category-leading. Working with Dana, our talented Health family plays a key role in helping to build and grow our agency’s story – from new product and campaign launches to innovative new technologies for clients that fuel our continued growth.”

Under Maiman’s leadership, the FCB Health Network has achieved unprecedented growth, with revenue more than quadrupling and its family jumping to over 1,700 professionals worldwide. In a challenging and heavily regulated healthcare environment, influenced by factors like expiring patents, failed clinical trials and aggressive M&A activity, Maiman has led the agency to historic new business success and monumental organic growth. Today FCB Health’s blue-chip client roster includes 18 of the top 20 global healthcare companies, and its agencies have racked up nearly every award, including Area 23’s historic 2017 Manny Awards trifecta win of Agency of the Year (Category 1), Most Creative Agency (third consecutive year) and Most Admired Agency (second consecutive year).

A consummate visionary marketer who produces epic results, Maiman considers her biggest success to be the incredible relationships she’s built with her team, her peers and her clients. She is credited with helping launch careers across the industry, mentoring tomorrow’s promising talent, and her counsel is valued by some of the greatest leaders in healthcare. It’s these relationships that Dana values above all else.

Throughout her 20 years of client service and healthcare marketing experience, Maiman has worked on virtually every therapeutic category – from antibacterials, women’s healthcare and cardiovascular to diabetes, oncology and HIV – in a multichannel fashion, integrating professional, consumer, patient, payer and digital. Maiman has also been involved with numerous U.S. and global launches, including Vioxx, Cialis, Yervoy, Gilenya, Januvia, Singulair AR, Fosamax Once-Weekly and Nuvigil, among others. Her robust client list includes pharmaceutical companies large and small, such as Boehringer Ingelheim, Merck, GSK, Pfizer, Gilead, Roche, Amgen and Novartis.

Rich Levy, chief creative officer of FCB Health, stated, “It is a true honor to work closely with Dana, as we continue to build on the agency’s existing successes and reach even greater heights in 2017. The healthcare industry is always evolving, and Dana constantly embraces the challenge of change and inspires our network worldwide.”


About FCB Health
With more than 30 years of experience marketing to healthcare professionals, patients and consumers, FCB Health produces work that is both strategically relevant and creatively compelling. The agency provides its clients with multichannel capabilities, including DTC and HCP communications, professional education, branding, scientific services, strategic planning and media services. Its high energy, diverse culture and global network have resulted in a robust client roster, including AbbVie, Allergan, Amgen, Boehringer Ingelheim, Ironwood, J&J, Lilly, Novartis and Genentech. It was named “Agency of the Year” by Med Ad News in 2006, 2009 and 2015 and by Medical Marketing & Media in 2007, 2010 and 2013. For the past seven out of eight years, an FCB Health Company was named Most Creative Agency by Medical Advertising News.

FCB Health is a unit of FCB, itself a member of the Interpublic Group (NYSE: IPG). Under its network umbrella, FCB Health has an impressive roster of separate full-service, multichannel healthcare agencies, including Area 23, Neon and FCB Cure, as well as units focusing specifically on managed markets and medical education: Mosaic, ProHealth, Hudson Global and Trio. For more information, visit

About FCB
FCB (Foote, Cone & Belding) is a global, fully integrated marketing communications company with a heritage of creativity and success dating from 1873. Based on a deeply developed understanding of diversified local markets and global cultures, FCB focuses on significantly changing consumer behavior to the benefit of its clients, its people and society. With more than 8,000 people in 109 operations in 80 countries, the company is part of the Interpublic Group of Companies (NYSE: IPG). Learn more at and follow us on Twitter and Instagram (@FCBglobal) and Facebook (FCB Global).